Eventually he was referred to a Boston rheumatologist who “changed my life by just listening to me, being kind and ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

Soligenix (NASDAQ:SNGX – Get Free Report) is expected to be announcing its earnings results before the market opens on ...

Soligenix (NASDAQ:SNGX – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on ...

Although BD may affect almost any system of the body with exacerbations and remissions of inflammation, the key clinical manifestations are recurrent oral aphthous ulcers, genital ulcers ...

Behçet's disease (BD) is a multisystem inflammatory disorder currently classified as a vasculitis. Its etiopathogenesis is unclear, but environmental, genetic and autoimmune factors have been ...

for oral ulcers associated with Behçet’s disease. Meanwhile, a new subcutaneous formulation of Takeda’s Entyvio (vedolizumab) – currently given as an intravenous infusion – was ...

EQS-News: Benzinga / Key word(s): Science Improving Patient Quality Of Life: Soligenix Progresses Treatment For Painful Ulcers Associated With Rare Behcet's Disease 21.02.2025 / 15:04 CET/CEST The ...

To date, various clinical manifestations, including aphthous ulcers are treated with limited success. Rebamipide is an anti-ulcer, gastro-protective drug, that increases mucous and stimulates ...

One had thrombophlebitis, digital vasculitis, perianal fistula, and paracolic abscess; the other had conjunctivitis and an ulcer in the natal cleft. Treatment with prednisolone, methyl prednisolone, ...